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Abstract
Background—Cleft lip with or without cleft palate (CL/P) and cleft palate only (CPO) are 
common congenital malformations. Numerous epidemiologic studies have shown an increased risk 
for orofacial clefts among children whose mothers smoked during early pregnancy; however, there 
is concern that the results of these studies may have been biased because of exposure 
misclassification. The purpose of this study is to use previous research on the reliability of self-
reported cigarette smoking to produce corrected point estimates (and associated credible intervals) 
of the effect of maternal smoking on children’s risk of clefts.
Methods—We accounted for misclassification using 4 Bayesian models that made different 
assumptions about the sensitivity and specificity of self-reported maternal smoking data. We used 
results from previous studies to specify the prior distributions for sensitivity and specificity of 
reporting and used Markov chain Monte Carlo algorithms to calculate the posterior distribution of 
the effect of maternal smoking on children’s risk for CL/P and CPO.
Results—After correcting for potential sources of misclassification in data from the National 
Birth Defects Prevention Study, we found an increased risk of CL/P among children born to 
mothers who smoked during early pregnancy (posterior odds ratio [OR] =1.6, 95% credible 
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interval = 1.1–2.2). The posterior effect of smoking on CPO provided less evidence of effect 
(posterior OR = 1.1, 95% credible interval = 0.7–1.7).
Conclusion—Our results lend some credibility to the hypothesis that periconceptional maternal 
smoking increases the risk of a child being born with CL/P. The results concerning CPO provide 
no overall evidence of effect, although the estimates were relatively imprecise. We suggest that 
future research should emphasize validity studies, especially those of differential reporting, rather 
than replicating existing analyses of the relationship between maternal smoking and clefts. We 
discuss how our approach is also applicable to evaluating misclassification in a wide range of 
exposure-outcome scenarios.
Effect estimates in epidemiologic research are subject to bias from confounding, selection 
bias, and misclassification. Case-control studies are particularly vulnerable to bias from 
reporting errors. In case-control studies of birth defects, when exposure information is 
gathered after a birth defect has occurred, the accuracy of maternal recall may depend on the 
presence of the birth defect. Rich literature has developed in recent years to account and 
correct for potential biases in the analysis of observational data.1–4 We present a case study 
for general methods to correct for exposure misclassification.
Orofacial clefts, defined either as cleft lip with or without cleft palate (CL/P) or cleft palate 
only (CPO), are common congenital malformations that occur in roughly 1.0/1000 births 
and 0.6/1000 births, respectively.5 Exposures that have been associated with risk for facial 
clefts include maternal folic acid consumption,6 family history of clefts,7–10 sex of the 
infant,11,12 maternal age,12–14 maternal education,15 maternal obesity,16 and race.17,18 
Numerous epidemiologic studies have shown that cigarette smoking during early pregnancy 
is also associated with an increased risk of clefts.19–24 A recent meta analysis by Little et 
al25 showed an increased risk for CL/P (odds ratio [OR] = 1.34, 95% confidence interval = 
1.25–1.44) and CPO (1.22 [1.10–1.35]) among children born to women who reported 
smoking during pregnancy. These modest elevated risks were reasonably homogeneous over 
15 studies of CL/P and 13 studies of CPO.
Almost all studies that have examined the relationship between maternal smoking and facial 
clefts have been case-control designs, with maternal smoking during pregnancy reported 
following pregnancy. Despite the relatively consistent association with maternal smoking 
seen across studies, there remains the possibility of differential maternal reporting of 
smoking status by mothers of infants diagnosed with clefts. Some authors have stated that 
misclassification by reporting bias is an unlikely explanation for the observed effects25; 
however, to our knowledge, no attempts have been made to quantify this. We used data from 
the National Birth Defects Prevention Study and previous research on the reliability of self-
reported smoking data to produce point and interval estimates of the effect of maternal 
smoking on children’s risk of facial clefts, correcting for uncertainty in the validity of self-
reported smoking data.
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The National Birth Defects Prevention Study is a multisite population-based case-control 
study that began enrolling women with an estimated date of delivery on or after October 1, 
1997. The study has been described in detail elsewhere.26,27 Infants with any of more than 
30 types of birth defects were eligible for enrollment; we limited our analysis to infants 
diagnosed with CL/P (bilateral, unilateral, central, or not specified) or CPO. All sites used 
standard case definitions and clinical review.27,28 In addition to the case review at each site, 
all infants with a diagnosis of facial clefts were reviewed by a clinical geneticist. Case 
infants were ascertained from population-based birth defects surveillance systems, and 
control infants were chosen randomly from all live-born infants within the study area who 
did not have a congenital defect, and who were selected either from birth certificate files or 
from delivery logs of birth hospitals. The data in this analysis come from 9 study sites: 
Arkansas, California, Iowa, Georgia, Massachusetts, New Jersey, New York, North Carolina, 
and Texas. Telephone interviews were conducted with birth mothers of case and control 
infants within 2 years after the infants’ estimated date of delivery. The response rates were 
76% among mothers of children with CL/P, 75% among mothers of children with CPO, and 
69% for controls for this time period in this analysis. Among other questions, mothers were 
asked about their smoking habits before and during pregnancy. Our main exposure of 
interest was maternal smoking (yes/no) during the periconceptional period, which we 
defined as 1 month before becoming pregnant through 3 months after becoming pregnant. 
We analyzed data from version 5.06 of the dataset, which includes infants born from 
October 1997 through December 2003. This dataset overlaps considerably with the one used 
by Honein et al20 in their recent study of facial clefts and maternal smoking, but 
incorporates 2 additional years of data.
Statistical Methods
We used the directed acyclic graph (DAG) shown in Figure 1 to help guide our model 
specification. In this DAG, smpre is the unobserved value that a woman would have reported 
for her periconceptional smoking status had she been asked about her smoking status during 
the periconceptional period, and smpost is the periconceptional smoking status she reported 
after giving birth. Z is a vector of possible confounders: maternal age (≤35 years, >35 years), 
first-degree family history of OFC (yes, no), maternal race and ethnicity (non-Hispanic 
white, non-Hispanic black, Hispanic, other), any folic acid supplementation in the 
periconceptional period (yes, no), maternal education (≤12 years, >12 years), maternal 
obesity prior to index pregnancy (body mass index ≥30, <30), and any alcohol use during the 
periconceptional period (yes, no). Facial cleft was the outcome of interest; however, in all 
models we analyzed CL/P and CPO separately because they arise along different etiologic 
pathways. If we knew smpre, we could have easily estimated its effect through a logistic 
model, adjusting for confounders Z; however, lacking that information, we needed further 
assumptions to estimate the effect. We treated smpre as measured with error by smpost and 
used information from previous research29 on the sensitivity and specificity of self-reported 
maternal smoking data to produce corrected estimates.
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We specified 3 regression models to characterize the DAG in Figure 1: an outcome model 
that specified the probability of facial clefts as a function of smpre (arrow C) and the other 
covariates, Z (arrow E); a measurement model that specified the probability of smpost as a 
function of smpre (arrow A) and clefts (arrow B); and an exposure model that specified the 
probability of smpre as a function of the covariates, Z (arrow D). We estimated these 3 
regression models jointly, allowing simultaneous imputation of smpre and estimation of its 
effect on clefts risks. Exposure misclassification can be handled in frequentist30,31 or 
Bayesian32–34 inference. We adopted a Bayesian framework35–37 here for both theoretical 
and pragmatic reasons. From a theoretical perspective, the availability of sensitivity and 
specificity estimates for self-reports of maternal smoking from previous research argues 
strongly for a Bayesian approach as outlined by Gustafson et al.38 More pragmatically, the 
joint estimation of these 3 models would be extremely cumbersome in frequentist inference, 
and reasonably straightforward in Bayesian inference.
The Outcome Model
We modeled the probability of an infant having an orofacial cleft with a logistic regression 
conditional on the (unknown) maternal smoking status during the periconceptional period 
and on potential confounders:
(1)
where β1 is the effect of periconceptional smoking, and θ is a vector of effects of the 
potential confounders in the vector . We note that this model assumes there is no 
interaction between smoking and other factors, but could be altered to include one. A proper 
Bayesian analysis required us to place prior distributions on unknown parameters. We used a 
non-informative N(0,106) (where N(a,b) stands for a normal distribution with mean = a and 
variance = b) for the prior distribution of the intercept term, and informative priors for other 
coefficients in the model. We placed informative priors on the remaining parameters in 
expression (1). These informative priors are intended to express our prior belief regarding 
the magnitude of the ORs for these variables. Prior studies and expert opinion were used to 
inform these prior distributions (Table 1). We used a relatively vague prior for the effect of 
smoking on the risk of clefts because potential misclassification in previous research made it 
difficult to specify an informative prior. It is important to note that the model specified in 
expression (1) is for prospective data (such as data from a cohort study) and does not exactly 
represent the way these case-control data were collected. This could be problematic when 
the exposure is misclassified; however, Gustafson et al39 provide reassurance that with a 
large dataset, this misspecification is unlikely to bias results.
Exposure Model
In addition to placing prior distributions on the coefficients in expression (1), we also placed 
a prior distribution on the unknown variable smpre. The exposure model accomplishes this 
by expressing the probability of reporting periconceptional smoking when asked during 
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early pregnancy as a function of the predictors in . This model allowed us to account for 
differences in smoking probability among various groups of women.
(2)
Here, ω is a vector of the effects of the predictors in , and ω0 is the intercept. The outcome 
is reported smoking status in the periconceptional period, which is not commonly observed 
in studies. This makes it difficult to use the results of previous studies to inform priors for 
parameter estimates. We placed N(0,1) priors on coefficients in this model, implying we are 
95% certain the true OR relating any exposure with reported periconceptional smoking 
status lies between, roughly, OR = 1/7 and OR = 7. Additional prior specifications are 
considered in the eAppendix (available in the online version of this article).
Measurement Model
The last of the 3 regression models is the measurement model, in which the probability that 
a woman reports periconceptional smoking after delivery, , depends on her smoking 
status during the periconceptional period and whether her child was diagnosed with a cleft. 
Notice that because  may depend on the outcome, we are allowing for differential 
misclassification:
(3)
The parameters in expression (3) correspond to the sensitivity and false-positive rate (FPR, 
or 1-specificity) of reported maternal smoking among case and control mothers. The 
probability of reporting smoking after delivery is separated into mutually exclusive 
components depending on case/control status and maternal report of smoking: α0 is the 
sensitivity of reported smoking among control mothers, α1 is the FPR among control 
mothers, α2 is the sensitivity among case mothers, and α3 is the FPR among case mothers. 
We used the exposure model and the measurement model to impute values of smpre in a 
manner analogous to that used with missing data techniques; we then used those imputed 
values to estimate the effect of periconceptional smoking on children’s OFC risk. The data, 
however, contain little information about the 4 parameters in the measurement model, so 
prior specification for these parameters can have a large impact on inference.
To examine the impact that misclassification might have had on the effect of smoking and 
clefting risk, we implemented 4 models that specify α0, α1, α2, and α3 in the measurement 
model by using different prior distributions. Model 1, our reference model, is based on the 
assumption that the periconceptional smoking status reported by women after their delivery 
is the same as what they would have reported had they been asked during their 
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periconceptional period. In terms of the measurement model specified previously, this 
translates into the assumption that α0 = α2 = 1, and (1 − α1) = (1 − α3) = 1. With the 
parameters in expression (3) fixed at , the outcome model (1) simplifies to:
Combined with the priors for β0, β1, and θ outlined previously, this is a standard Bayesian 
logistic regression model.
Model 2 is based on the assumption that women’s smoking was differentially misclassified 
but the amount of the misclassification is known with certainty. The corrections made in 
analyses based on this model are roughly equivalent to common corrections for 
misclassification seen in the epidemiologic literature.40 It has been shown that such an 
approach can be highly sensitive to even small discrepancies between the assumed and 
actual values of sensitivity and specificity.38,41 There are few data on the reporting of 
maternal smoking during pregnancy that could help us quantify the sensitivity and 
specificity of self-reported smoking data for case and control subjects. We are aware of no 
studies that provide information on accuracy of smoking reporting among mothers of infants 
with clefts and only 1 study that provides information on accuracy of smoking reporting 
among mothers of infants with congenital malformations.29 In that study, conducted in the 
Netherlands in 1978 and 1979, women were asked about their smoking status at 
approximately the 18th week of gestation and again following delivery. Congenital 
malformations were found in 40 infants, allowing rather imprecise estimates of sensitivity 
and specificity to be generated for case mothers, whereas 2320 infants were born at term 
without any malformation, allowing more precise estimates of sensitivity and specificity 
among control mothers. The parameters we specified in the measurement model (3) were 
equal to the maximum likelihood estimates of sensitivity and FPR (among case and control 
mothers) estimated from data reported in this article: α0 = 0.91, α1 = 0.06, α2 = 0.94, and 
α3 = 0.09.
Model 3 is based on the assumption that the sensitivities and FPRs used in the measurement 
model (2) are unknown (rather than constant and known with certainty) and reflects concern 
about using even slightly inaccurate values of sensitivity and specificity to correct for 
misclassification. Because sensitivities and FPRs must fall between 0 and 1, a natural choice 
for a prior distribution is a beta distribution, which gives support only to values between 0 
and 1. The beta distribution is defined by 2 parameters, b1 and b2, and has a mean of b1/(b1 
+ b2). The parameters b1 and b2 can be interpreted as the number of “successes” and 
“failures” in some trial, respectively. For sensitivities, b1 is the number of women who report 
smoking after delivery and in early pregnancy and b2 is the number of women who report 
not smoking after delivery but report smoking in early pregnancy. For FPRs, b1 is the 
number of women who report smoking after delivery but not during early pregnancy, and b2 
is the number of women who report not smoking after delivery and not smoking during early 
pregnancy. The prior distributions for sensitivity and FPR among case and control mothers 
that we use in Model 3 are shown in Figure 2. Because of the difference in the number of 
case and control mothers in the validation study (40 versus 2320), the estimates of sensitivity 
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(mean = 0.91, 95% CI = 0.89–0.93) and FPR (mean = 0.06, 95% CI = 0.04–0.07) among 
control mothers were more precise than the estimates of sensitivity (mean = 0.94, 95% CI = 
0.81–1.0) and FPR (mean = 0.09, 95% CI = 0.01–0.24) among case mothers. We present 
analyses in the eAppendix using different prior specifications.
In Models (1), (2), and (3), we use data from previous studies on maternal reporting of 
smoking to impute values of a woman’s smoking status during the periconceptional period. 
The gold standard used in the previous studies was self-report of smoking during early 
pregnancy. Additional reporting bias is possible, however, and self-report during early 
pregnancy may not be an accurate description of a woman’s true smoking status. In 
particular, women who smoke during early pregnancy may underreport their smoking. This 
may be the reason for the surprisingly low specificities observed in previous research29: 
women who reported not smoking during early pregnancy but who did report smoking later 
during their pregnancy may have truly smoked during the periconceptional period but did 
not accurately report it. In this scenario, as depicted in Figure 3, an additional measurement 
model must be specified for the probability of reporting smoking during the periconceptional 
period given true smoking status (arrow F). Previous studies have examined the validity of 
women’s self-reported smoking status during pregnancy by comparing their reported status 
with levels of cotinine found in their blood or urine.42–45 Two of these studies collected data 
in the 1960s and 2 in the 1990s. Because estimates of sensitivity and specificity in the 4 
studies were very similar, we pooled the data from the 4 studies to generate a single 
estimate. The pooled FPR estimate indicates that women who were truly not smokers rarely 
reported that they were (mean = 0.02, 95% CI = 0.02–0.03), whereas the pooled sensitivity 
estimate indicates that some women who did smoke reported that they did not (mean = 0.92, 
95% CI = 0.91–0.93). In Model 4 we combine the outcome, exposure, and measurement 
models we defined in Model 3 with an additional measurement model that corrects for 
response bias:
(4)
Here, γ0 is the sensitivity of reported smoking, and γ1 is the FPR. In contrast to the 
measurement model in expression (3), this one is nondifferential. We placed beta priors on 
the sensitivity and FPR in this model, with parameters corresponding to the pooled estimates 
described previously.
We performed a number of sensitivity analyses to judge the influence of our prior 
assumptions in the exposure and measurement models. We also performed additional 
analyses examining the effect of maternal smoking on isolated clefts (those having no 
additional major defects) and multiple defects (major unrelated defects in 2 or more different 
organ systems); these are shown in the eAppendix. We fit all models using Markov chain 
Monte Carlo (MCMC) algorithms in OpenBUGS and R.46,47 The code needed to fit these 
models is also shown in the eAppendix. MCMC algorithms were run for 20,000 iterations, 
with the first 1000 iterations excluded as a burn-in period. We ran multiple chains from 
different initial positions and visually examined trace plots to monitor convergence. 
Following the burn-in period, the iterations of the MCMC algorithm are random draws from 
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the posterior distributions of interest. The median of these random draws was exponentiated 
to obtain the posterior OR of interest, and the 2.5th and 97.5th percentiles of the random 
draws were exponentiated to obtain posterior credible intervals.
RESULTS
The National Birth Defects Prevention Study enrolled 6909 infants who met our case and 
control definitions (4874 controls, 1323 with CL/P, and 712 with CPO). As shown in Table 
2, control mothers were less likely to be non-Hispanic white and less likely to report a 
family history of clefts than mothers of infants with either CL/P or CPO. The observed ORs 
in Table 2 are consistent with the prior specification in Table 1.
The 4 models, run separately for CL/P and CPO, converged relatively quickly. Posterior ORs 
and 95% credible intervals are shown in Table 3. Model 1, which did not correct for 
exposure misclassification, indicated a slight increased risk for CL/P and CPO among 
children of mothers who reported periconceptional smoking. Estimates from Model 2, which 
corrected for misclassification but treated the sensitivity and specificity of misclassification 
as known with certainty were shifted toward the null. Estimates from Model 3, which treated 
the sensitivity and specificity as unknown, had wider credible intervals and showed a greater 
association between maternal smoking and CL/P risk than the estimates from Model 2, but a 
similar association between maternal smoking and CPO risk. Estimates from Model 4, 
which incorporated additional information on self-reported smoking relative to cotinine 
levels were similar to those from Model 3.
Results of sensitivity analyses shown in the eAppendix indicated that varying the 
assumptions regarding prior distributions of coefficients in the outcome or exposure model 
did not result in any substantial changes to inference. Varying the prior distributions for the 
FPR and sensitivity resulted in wider posterior credible intervals but little change in 
posterior ORs.
DISCUSSION
After accounting for smoking misclassification, we found an increased risk for CL/P among 
infants of mothers who smoked during the periconceptional period. The effect of maternal 
periconceptional smoking on children’s CPO risk was less clear, with a posterior effect near 
the null but imprecise credible intervals.
Model 1 was a standard Bayesian logistic regression that assumed perfect sensitivity and 
specificity of maternal reporting. This model produced effect estimates of periconceptional 
maternal smoking on children’s risk for CL/P and CPO that were very similar to meta-
analysis estimates by Little et al.25 The large size of our dataset ensured estimates were 
robust to prior specification for this model (see eAppendix); our results using the first 
Bayesian model were virtually identical to the frequentist results reported by Honein et al.20 
Model 2, which corrected for maternal reporting bias by treating sensitivity and specificity 
as known constants, resulted in smaller estimated effects. The sensitivities and specificities 
we specified would be expected to produce differential misclassification away from the null, 
so corrected estimates will naturally move toward the null. In these data, the combination of 
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lower specificity among cases than controls resulted in a relative surplus of infants 
categorized as exposed cases.
Model 3, which allowed sensitivities and specificities to be unknown, produced posterior 
effect estimates that were larger than those produced by Model 2. When uncertainty in 
maternal reporting was accounted for in this model, there was still evidence that 
periconceptional smoking had an effect on CL/P; however, there was far less evidence of an 
effect of smoking on CPO.
It is interesting to note that Model 3 resulted in different estimates for CL/P than Model 2. 
Because Model 2 treats sensitivities and specificities as known with certainty, the posterior 
values for the sensitivity and specificity parameters will always be identical to their priors: 
no amount of data can change them. Sensitivities and specificities in Model 3, on the other 
hand, adapt in light of the data. Many of the variables in Z are predictive of maternal 
smoking, and these variables were used to impute the unobserved periconceptional smoking 
status for each woman. The sensitivity and specificity parameters were then updated in light 
of how well these imputed variables corresponded to observed smoking status. Among 
mothers of infants with CL/P, the data imply smoking is reported more accurately than our 
prior indicated. In fact, the posterior distribution for specificity among cases had a mean of 
0.96 and 95% credible intervals (0.93–0.99) that did not include the fixed estimate of 0.91 
used in Model 2. The results for CPO were somewhat similar to those in Model 2 because, 
due to the smaller sample size of CPO cases, the posterior distribution of sensitivity and 
specificity was not very different from the priors and still centered near the values used for 
correction in Model 2. Estimates from Model 4 are largely unchanged relative to Model 3. In 
some of the additional analyses presented in the eAppendix, the additional uncertainty 
incorporated in Model 4 produces somewhat more imprecise credible intervals. The effect of 
maternal smoking on children’s risk for CL/P produced by Model 4 was quite similar to that 
found in one cohort study, although estimates of the association between smoking and CPO 
risk were somewhat different.48 A more recent cohort study with very little misclassification 
of maternal smoking, published while our paper was in press, found very similar results to 
ours.49
The study we used to help quantify the sensitivity and specificity of self-reported smoking 
status among case and control mothers is not ideal (nor is the additional study we include in 
the eAppendix). It was not conducted in a population similar to that participating in National 
Birth Defects Prevention Study or collected in the same decade. Given the divergent and 
changing attitudes toward smoking over time and in different countries, it is not clear how 
well the sensitivities and specificities in the study we used mimic those that would have been 
found in our source population. Additionally, the time between delivery and the 
postpregnancy interview was typically shorter in that study than in our data. For these 
reasons, Models 3 and 4 (which assume the effect estimate is not known with certainty) are 
particularly appealing. A typical analysis of these data would assume perfect recall (as in 
Model 1), and underestimate our true uncertainty of the effect of smoking on risk of clefts. 
Our ability to introduce uncertainty about the accuracy of recall and have that uncertainty 
reflected in the posterior ORs and credible intervals is a major benefit of this approach. 
Furthermore, we assumed that all variables in our model, other than smoking, were 
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measured without error; we did not consider other types of errors that may also bias results. 
For example, we cannot rule out selection bias as a possible source of error if, for instance, 
case mothers who smoked during the periconceptional period were more likely to enroll than 
nonsmoking case mothers, or if maternal smoking had a selective impact on embryonic and 
fetal survival. The models we propose, however, could easily be adapted to incorporate this 
information if there were reasonable prior values.
Whether periconceptional smoking has an effect on the risk of facial clefts is not likely to be 
solved with further case-control studies, at least not without significant modification in how 
and what data are collected. In any event, extensive simulation studies would be needed to 
evaluate power in complicated settings such as the one we considered, although results and 
some formulae are provided for simpler settings of exposure misclassification in 
Gustafson.50 The estimates from Model 1 (in which misclassification is ignored) are precise; 
however, the width of the credible intervals about the estimates nearly doubled when we 
accounted for misclassification. The imprecision of these effects is partially due to our lack 
of information about the validity of maternal self-report of smoking during pregnancy; 
future studies focusing on the validity of maternal reporting (especially in relation to case 
status) would have a large impact in decreasing the uncertainty of these effects.
We have focused on a particularly interesting example, the effect of periconceptional 
maternal smoking on risk of facial clefts. Recall bias or differential misclassification 
represents a common concern in birth defects and pediatric epidemiology, but this scenario 
has broader applicability.
Results of numerous case-control studies have shown that maternal smoking during 
pregnancy is associated with an increased risk for of clefts; however, the interpretation of 
these effects is difficult due to the possible presence of reporting bias. The models we 
present correct for reporting bias and lend some support to the hypothesis that 
periconceptional smoking is associated with an increased risk for CL/P. The results 
concerning CPO are more mixed with little overall evidence of effect but less precise 
estimates.
These methods have broad applicability in other misclassification settings as well. The 
general strategy of specifying an exposure, measurement, and outcome model based on a 
DAG and jointly estimating modes in BUGS should be transportable to other studies. 
Clearly, misclassification can occur in prospective as well as retrospective studies and some 
alterations of the DAG may be necessary for these studies. For instance, arrow B in Figures 
1 and 2 would not typically be present when the exposure measurement is made prior to the 
occurrence of the outcome. However, only minor modification of the code provided in the 
appendix would be necessary to run these models in other settings. Care should always be 
taken when specifying prior distributions. Insufficiently informative priors in either the 
exposure model or the measurement model may lead to poorly behaved MCMC algorithms. 
Generally speaking, the further the sensitivities and specificities are from 1.0, the greater the 
difference between the crude and adjusted OR could be. Furthermore, if a great deal is 
known about the sensitivity and specificity of recall, the results of Model 3 (or Model 4) will 
not differ much from the results of Model 2. Conversely, as the uncertainty regarding recall 
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increases, Models 3 and 4 (which propagate that uncertainty through the model) will be 
particularly appealing.
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Directed acyclic graph (DAG) illustrating the relationship between women’s self-reported 
periconceptional smoking status during early pregnancy and late pregnancy and their 
children’s risk for orofacial clefts. Z is a vector of confounding variables.
MacLehose et al. Page 14














Prior distribution for sensitivity (right half of plot) and 1-specificity (left half of plot) in 
cases (dashed line) and controls (solid line) for report of maternal smoking, based on 
estimates from Verkerk et al.29
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Directed acyclic graph (DAG) illustrating the relationship between women’s true smoking 
status, self-reported periconceptional smoking status during early pregnancy and late 
pregnancy, and their children’s risk for facial clefts. Z is a vector of confounding variables,
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TABLE 1
Prior Odds Ratios (ORs) and 95% Credible Intervals Used in the Outcome Model for Cleft Lip With or 
Without Palate (CL/P) and Cleft Palate Only (CPO)a
CL/P Prior OR
(Prior 95% Credible Interval)
CPO Prior OR
(Prior 95% Credible Interval)
Report periconceptional smoking
 No   1.0   1.0
 Yes   1.0 (0.1–7.1)   1.0 (0.1–7.1)
Periconceptional folic acid use6
 No   1.0   1.0
 Yes   0.8 (0.6–1.0)   1.0 (0.5–2.0)
Maternal age (y)12–14
 <35   1.0   1.0
 ≥35   1.0 (0.7–1.5)   1.3 (1.0–1.7)
Family history of OFC7–10
 No   1.0   1.0
 Yes 15.0 (5.6–40.0) 15.0 (5.6–40.0)
Maternal race/ethnicity17,18
 Non-Hispanic white   1.0   1.0
 Non-Hispanic black   0.5 (0.4–0.6)   0.7 (0.5–0.9)
 Hispanic   0.9 (0.5–1.5)   0.8 (0.6–1.0)
 Other   1.0 (0.5–2.0)   1.0 (0.5–2.0)
Gravidity
 Primigravid   1.0   1.0
 Multigravid   1.0 (0.5–2.0)   1.0 (0.5–2.0)
Obese16
 No   1.0   1.0
 Yes   1.3 (0.9–1.9)   1.2 (0.8–1.7)
Maternal education
 ≤12 y   1.0   1.0
 >12 y   1.0 (0.5–2.0)   1.0 (0.5–2.0)
Periconceptional alcohol use
 No   1.0   1.0
 Yes   1.0 (0.5–2.0)   1.0 (0.5–2.0)
a
Some of the relevant studies used to help inform prior knowledge are indicated in superscripts.
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TABLE 3
Results of Bayesian Correction of Maternal Smoking in Estimating the Association Between Maternal 
Smoking and Children’s Risk for Oral Clefts, National Birth Defects Preventions Study, 1997–2003
Model Model Assumptions for Misclassification CL/P ORa (95% 
Credible Interval)
CPO ORa (95% 
Credible Interval)
1 No misclassification 1.3 (1.1–1.6) 1.2 (1.0–1.5)
2 Misclassification with known sensitivity and specificity with maternal 
report as gold standard
1.2 (0.9–1.5) 1.0 (0.7–1.3)
3 Prior distributions on sensitivity and specificity, with maternal report as 
gold standard
1.5 (1.1–2.1) 1.1 (0.7–1.6)
4 Prior distributions on sensitivity and specificity, with cotinine levels used 
as gold standard
1.6 (1.1–2.2) 1.1 (0.7–1.7)
a
OR is the posterior odds ratio.
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